Mar 31, 2017

EU antitrust official mum on Google antitrust probe

European Union Competition Commissioner Margrethe Vestager dodged commenting on when the bloc might resolve its antitrust cases against Google during a conversation with reporters in Washington:

"The Google cases are moving forward. They are high priority. But it is, as always, very difficult to give any kind of deadlines because we don't know what happens sort of in the process, things can still come up that we'll need to spend time on. You know that the procedural rights, they are important for us, and therefore it is very difficult to say when we will have a conclusion of the first, the second and the third Google case. But they are, of course, still very high priority."

Why it matters: Vestager's three cases against Google are closely watched because of the company involved, but also because they underscore Europe's broader willingness to take on American tech companies. The commissioner has denied harboring a bias against U.S. businesses.

Go deeper

Remembering George Floyd

Photo: Kerem Yucel/AFP via Getty Images

With politicians, clergy and law enforcement in attendance on Thursday in Minneapolis, the family of George Floyd demanded recognition for his life well lived.

Why it matters: Floyd has become the latest symbol of police brutality after he was killed last week when a police officer held a knee to his neck.

Al Sharpton says Floyd family will lead march on Washington in August

The family of George Floyd is teaming up with Rev. Al Sharpton to hold a march on Washington on Aug. 28 — the 57th anniversary of the civil rights movement's March on Washington — to call for a federal policing equality act, Sharpton announced during a eulogy at Floyd's memorial service in Minneapolis Thursday.

Why it matters: The news comes amid growing momentum for calls to address systemic racism in policing and other facets of society, after more than a week of protests and social unrest following the killing of Floyd by a Minneapolis police officer.

2 hours ago - Health

Medical journal retracts study that fueled hydroxychloroquine concerns

Photo: George Frey/AFP via Getty Images

The Lancet medical journal retracted a study on Thursday that found that coronavirus patients who took hydroxychloroquine had a higher mortality rate and increased heart problem than those who did nothing, stating that the authors were "unable to complete an independent audit of the data underpinning their analysis."

Why it matters: The results of the study, which claimed to have analyzed data from nearly 96,000 patients on six continents, led several governments to ban the use of the anti-malarial drug for coronavirus patients due to safety concerns.